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A B S T R A C T
In England and Wales, approximately one half of all laboratory-conﬁrmed meningococcal disease cases fail to
yield a viable invasive isolate, primarily due to the use of antibiotics. Characterisation of non-culture me-
ningococci has been restricted to the detection or sequencing of speciﬁc gene targets within clinical specimens.
In this study we investigated the ability of the Agilent SureSelectXT kit to facilitate DNA enrichment and genome
sequencing of meningococcal DNA within a small panel of blood and CSF specimens. A target-speciﬁc RNA
oligonucleotide bait library was used to capture and enrich the bacterial DNA prior to next generation se-
quencing. A positive correlation between meningococcal DNA amount and genome coverage was observed with
eight of the ten specimens producing genomes of acceptable quality. All commonly-used typing information
derived from each acceptable non-culture genome matched those of an isolate from the same patient and the
paired genomes showed a high level of congruence across indexed loci. We estimate that this technique could be
used to perform whole genome sequencing on up to ∼45% of the positive specimens received by the Public
Health England’s Meningococcal Reference Unit. Further optimisation of the extraction and/or enrichment
processes may, however, increase the proportion of non-culture cases from which quality genomes can be ob-
tained.
1. Introduction
Despite the widespread use of eﬀective meningococcal vaccines,
Neisseria meningitidis continues to cause endemic and epidemic invasive
meningococcal disease (IMD) throughout the world (Ali et al., 2014;
Pelton, 2016). A new generation of protein-based vaccines is being
introduced with the aim of protecting against a greater proportion of
the diverse strains circulating within target populations (Gasparini
et al., 2014). Concurrently, due to developments in next generation
sequencing technology, whole genome sequencing (WGS) of meningo-
coccal isolates has become a routinely-used tool and provides invalu-
able information regarding genetic relatedness, antigenic distribution
and metabolic characteristics (Brehony et al., 2015; Lucidarme et al.,
2015; Watkins and Maiden, 2017).
Whilst WGS is more cost-eﬀective than ever before, a major lim-
itation is the requirement of viable bacteria from which suﬃcient
amounts of DNA can be extracted. In England and Wales, the early
administration of antibiotics prevents cultivation of meningococci from
clinical specimens (e.g. blood and CSF) in approximately one half of
laboratory-conﬁrmed IMD cases. These cases are conﬁrmed using real-
time PCR on DNA extracts from clinical specimens (Heinsbroek et al.,
2013). Although sequencing of important gene targets can be carried
out from these specimens (Clark et al., 2014), the low concentration of
meningococcal DNA and presence of human host DNA prevents WGS
using standard methods. The lack of genomic data in these cases limits
the scope of vaccine strain coverage predictions and prevents high-re-
solution multilocus sequence typing (MLST) analyses, which can form
the basis of the public health response to outbreaks and changes in IMD
epidemiology (Chatt et al., 2014; Parikh et al., 2017).
To overcome these limitations, a number of commercial DNA en-
richment strategies have been developed (Kozarewa et al., 2015). These
techniques allow the sequencing of speciﬁc exons, genomic regions or
whole genomes within mixed samples by purifying and concentrating
the desired DNA fragments. One such approach involves using speciﬁc,
biotinylated oligonucleotide baits that can hybridise to the target
genomic fragments. Streptavidin-coated magnetic beads are then used
to separate the hybridised fragments from the rest of the sample before
the isolated DNA is ampliﬁed and sequenced (Bodi et al., 2013). The
Agilent SureSelectXT Target Enrichment system, which uses a tailored
RNA bait library to capture the target DNA has been successfully used
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to enrich and sequence the genomes of herpesviruses, Chlamydia tra-
chomatis andMycobacterium tuberculosis directly from clinical specimens
(Brown et al., 2015; Christiansen et al., 2014; Depledge et al., 2011).
The aim of this work was to assess the eﬀectiveness of the SureSelectXT
system in facilitating WGS of diverse meningococcal strains directly
from clinical specimens and calculate the proportion of non-culture
cases conﬁrmed by the Public Health England Meningococcal Reference
Unit (MRU), that could be comprehensively characterised in this way.
2. Methods
2.1. Clinical specimens and DNA extraction
Clinical specimens were selected from group B IMD cases which also
yielded a viable isolate (from a separate sample). The corresponding
isolates had previously undergone WGS and the genomic data are
available within the PubMLST database (https://www.pubmlst.org/
neisseria) (Jolley and Maiden, 2010). The MLST data for these isolates
were used to select ten non-culture clinical specimens (ﬁve blood and
ﬁve CSFs) containing DNA from meningococci with distinct STs re-
presenting seven clonal complexes (and one singleton). The selected
clinical specimens and corresponding isolates are listed in Table 1.
The real-time PCR cycle threshold (Ct) values of the specimens,
derived using a ctrA-directed Taqman® assay (Heinsbroek et al., 2013),
varied from 20 to 39 (Table 1). The concentration of meningococcal
DNA within each specimen was estimated using previously-published
Ct values obtained from quantiﬁed meningococcal DNA extracts (Clark
et al., 2014). These values were used to generate a standard curve
against which the Ct values of the ten selected specimens could be
compared in order to estimate the meningococcal DNA concentration.
The estimated DNA concentrations were calculated to be from 2 fg/μL
to 153 pg/μL.
The available specimen volumes ranged from 40 to 300 μL. DNA
extraction was carried out using the EZ1 DNA Blood Kit on an EZ1
Advanced XL (Qiagen, UK) as per manufacturer’s instructions with an
additional bead-beating bacterial cell lysis step. Sample volumes of
300 μL were used. Specimens with available volumes of< 300 μL were
diluted in molecular grade water as required. The available specimen
volumes were used along with the calculated DNA concentrations to
estimate the total amount of meningococcal DNA available for extrac-
tion (Table 1).
2.2. In silico generation of 120mer RNA bait sequences
RNA baits of 120mer length were designed using sequences from 77
complete N. meningitidis genomes available on NCBI GenBank (www.
ncbi.nlm.nih.gov/genbank) and 2898 N. meningitidis whole/draft gen-
omes within PubMLST. These genomes represent a diverse array of
capsular groups and clonal complexes. A previously-designed in-house
Perl script was used to generate overlapping bait sequences to provide
2X coverage across all reference sequences (Depledge et al., 2011). The
in silico-generated sequences were re-mapped on to both human and N.
meningitidis genomes to check for speciﬁcity and major gaps in the bait
set. Additional baits were generated separately to match any gaps
identiﬁed and added to the overall bait set as required. Baits with
speciﬁcity to the human genome were removed. The bait library se-
quences were uploaded to SureDesign and the oligonucleotides were
manufactured by Agilent Technologies.
2.3. Library preparation and hybridisation
Preparation and enrichment of the Illumina sequencing libraries
was performed using the SureSelectXT reagent kit for the MiSeq se-
quencing platform (Agilent, US) in accordance with the manufacturer’s
instructions.
Brieﬂy, the Agilent SureSelectXT library preparation protocol Ta
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involved fragmentation of the DNA using a Covaris ultrasonicator
(Covaris, US) followed by puriﬁcation, end-repair and ligation of
Illumina adapters. The DNA was then ampliﬁed by adapter-mediated
PCR prior to in-solution hybridisation using the meningococcal-speciﬁc
RNA capture baits. Streptavidin-coated magnetic beads were used to
isolate the biotinylated baits and hybridised DNA fragments. The cap-
tured DNA was then once again ampliﬁed and indexed prior to multi-
plex sequencing.
2.4. Sequencing and genome assembly
Sequencing of captured DNA libraries was performed on an Illumina
MiSeq using the 500-cycle V2 kit (Illumina, US) in accordance with the
manufacturer’s protocol.
All reads were screened for human sequences by mapping to a
human reference genome (Hg19, accession number:
GCF_000001405.13) using BBMap (version 37.00). Unmapped reads
were corrected for predicted sequencing error using Lighter (Song et al.,
2014) and overlapping read pairs were merged with FLASH (Magoč and
Salzberg, 2011). All merged paired reads and unpaired reads were then
retrieved and de novo assembled using SPAdes (Bankevich et al., 2012)
without read error correction, assembler only, using k-mer values of 21,
33, 55, 77, 99 and 127.
2.5. Estimation of specimen genome coverage and read depth
To assess genome coverage, organise the assembled contigs and
remove possible contaminants (e.g. residual human sequences), the de
novo-assembled contigs from each sample were aligned to the most
closely-related complete meningococcal genome available in the
PubMLST database (Fig. 1). For each strain, the most closely-related
complete genome was identiﬁed through distance estimation based on
shared K-mers between 237 complete genomes available on PubMLST
and the corresponding isolate genome using Mash (Ondov et al., 2016).
The following complete genomes: NZ-05/33, M04-240196, M01-
240355 (Budroni et al., 2011), α710 (Joseph et al., 2010), MC58
(Tettelin et al., 2000), α153 (Schoen et al., 2008), 12–176 (no ref,
pubMLST ID 41342) and M22236 (Kretz et al., 2016) were used to
create pseudo-references (Table 2). The contigs for each specimen
genome were then aligned against the corresponding complete genome
using the BWA-MEM algorithm (Li, 2013). The consensus sequences for
the contigs aligned to the complete genomes were used as pseudo-re-
ferences against which the screened sequencing reads were re-mapped
to assess genome coverage and depth (Fig. 1).
2.6. Gene-by-gene comparison of specimen and isolate genomes
A gene-by-gene comparison of the specimen and corresponding
isolate sequence data was performed by submitting the de novo-as-
sembled contigs to the PubMLST database for automated gene anno-
tation (Fig. 1). Commonly used typing data: the seven MLST loci, PorA
VR1 and VR2, PorB, FetA VR, Factor H-Binding Protein (fHbp), Neis-
serial Heparin-Binding Antigen (NHBA) and Neisseria Adhesin A (NadA)
were extracted for each of the genome pairs and compared.
To expand the analysis to a wider panel of genes, the PubMLST
Genome Comparator tool was used to compare the paired genomes in
terms of all catalogued NEIS loci (n = 2652, accessed on 08/02/2017),
where present. Genes which could not be annotated due to missing
data/incomplete assembly in one or both of the paired genomes were
removed from the analysis and, among the remaining, characterised
loci, those which had diﬀering allele IDs were selected for further allelic
comparison. The alleles were aligned and compared to quantify the
number of discrepant bases. Single diﬀerences between two alleles were
considered to be due to PCR error or single nucleotide polymorphisms.
Genes with multiple diﬀerences were further analysed in order to better
explain the diﬀerences. BLAST searches were performed within the
available N. meningitidis genomes in NCBI Genbank in order to identify
multiple genes copies (paralogy) and/or matching gene fragments.
Fig. 1. Overview of analysis of meningococcal sequencing reads and
assembled contigs. Raw reads were screened by aligning to human
reference. Screened reads were de-novo assembled. Genome coverage
and read depth was estimated by aligning against a pseudo-reference
genome and the contigs were submitted to PubMLST to allow a gene-
by-gene comparison of non-culture and corresponding isolate gen-
omes.
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3. Results
3.1. Sequencing reads and screening of human reads
Table 2 lists the numbers of total read pairs generated from each
sample and numbers and proportions of those read pairs that mapped
onto the human reference and meningococcal pseudo-reference gen-
omes. The total number of read pairs generated from each specimen
varied from 1,594,558 to 3,276,069. The proportion of total read pairs
aligning to the human reference ranged from 28.8% to 91.5%. For eight
of the ten specimens,> 50% of the total reads were human derived.
The proportion of reads aligning to the pseudo-reference meningo-
coccal genomes ranged from 0.1% to 64.1% (Table 2) and correlated
positively with the calculated meningococcal DNA amount.
3.2. Meningococcal genome coverage and read depth
The closest-related complete genome for each sample, the estimated
genome coverage and sequencing read depth against the meningococcal
pseudo-reference consensus are listed in Table 2. The genome coverage
ranged from 7.2% to 98.6%, with eight of the ten genomes ex-
hibiting> 92% coverage of their respective pseudo-references. Overall,
a clear correlation was observed between the extracted meningococcal
DNA load, the median read depth and estimated genome coverage
(Fig. 2).
The two specimens with< 100 pg of DNA available (specimens 1
and 2) yielded low genome coverage (7% and 71%, respectively) and
‘shallow’ read depth (< 3 median depth). For the remaining specimens,
there was a positive correlation between the DNA amount used and the
median read depth, however, above this 100 pg threshold, the genome
coverage plateaued at 90–100% (Fig. 2).
3.3. Gene-by-gene, culture vs specimen genome comparison
One of the ten specimen genomes (specimen 1) was not accepted for
inclusion into the PubMLST database due lack of matches to Neisseria
loci. This sample had the highest Ct value (Ct 39), the lowest estimated
DNA load (423 fg) and the lowest estimated genome coverage (7.2%).
Table 3 provides details on contig properties and the indexed
genomic data extracted from PubMLST. Substantially more contigs
were produced from assembly of the specimen reads when compared to
the genomes of the isolates (specimen mean 1314 vs. 342 for isolates).
Excepting the two poor quality specimen genomes (specimens 1 and 2),
the cumulative contig length of the specimens was greater than the
corresponding isolate genomes. This is likely to be the result of en-
during host DNA, and/or DNA from environmental contaminants,
within the assembly.
Following automated gene annotation, genotypic data for common
typing targets were extracted from the nine specimen genomes and the
corresponding isolates (Table 3). Comparisons of the annotated loci
among specimen and isolate genomes revealed perfect concordance in
terms of commonly-used typing information. Four of the specimen
genomes yielded complete typing information, whilst the remaining
ﬁve genomes failed to cover at least one antigenic and/or MLST genes.
There was a clear correlation between the estimated amount of me-
ningococcal DNA present in the specimens and the coverage of the
typing loci. For all genomes with complete typing data,> 500 pg of
DNA had been utilised to create the sequencing libraries, whilst those
with< 500 pg available yielded incomplete data. The genomes with
complete data also exhibited higher median read depths (≥73x).
To expand the analysis, genome comparisons in terms of all NEIS
loci (n = 2652), where present, were carried out. The number of NEIS
loci that were covered by both the specimen and isolate genomes for a
given case (shared NEIS loci) varied from 945 to 1780 (Table 3). Fol-
lowing genome comparisons, 43 discrepant alleles were identiﬁed
across all genome pairs (from 0.11% to 1.16% of shared NEIS loci;
Table 3). The discrepant loci for each genome pair are listed in a
Supplementary Table 1. Genes with discrepant alleles that diﬀered at
more than one residue (23/43) were checked for possible paralogous
loci within NCBI Genbank genomes. All but one of the genes fea-
turing>1 bp polymorphisms were found to generate signiﬁcant addi-
tional hits in complete genomes within Genbank (Table S1). The alleles
of the remaining gene (NEIS0534) diﬀered by 4 bp between specimen 4
and isolate M15 240270. All four diﬀerences were within a 28 bp re-
gion of the ﬁrst half portion of the gene (all synonymous mutations). No
similar sequences were found among human genomes on NCBI Gen-
bank. This gene codes for a 30S ribosomal subunit (S16) and is highly
conserved amongst invasive strains (data not shown). The cause of
Table 2
Statistics for read alignment to human reference and meningococcal pseudo-reference consensus for each clinical specimen.
Sample No. of read
pairs
No. of reads mapped
to human reference
% of reads
mapped to human
ref.
Closest-related
complete genome
No. of reads mapped
to NM pseudo-ref.
% of reads mapped
to NM pseudo-ref.
% genome
coverage≥ 1 x
Median read
depth
1 1,913,131 1,749,684 91.5 alpha710 1112 0.1 7.2 0
2 1,796,259 1,627,329 90.6 NZ-05/33 22,865 1.3 70.8 2
3 1,769,239 1,518,863 85.8 M04 240196 84,281 4.8 93.7 10
4 1,819,385 1,521,127 83.6 alpha153 124,710 6.9 96.4 14
5 1,932,925 1,635,041 84.6 M22236 134,565 7.0 92.4 17
6 1,802,516 1,562,163 86.7 MC58 91,072 5.1 93.8 10
7 1,959,202 1,070,035 54.6 M01 240355 730,805 37.3 98.1 89
8 2,358,677 964,492 40.9 M04 240196 1,250,017 53.0 98.6 149
9 1,594,558 898,513 56.3 M04 240196 563,338 35.3 96.7 73
10 3,276,069 944,227 28.8 12–176 2,098,332 64.1 95.6 254
NM= Neisseria meningitidis.
Fig. 2. Correlations between the estimated meningococcal DNA load in each specimen (X
axis) and the median read depth and genome coverage. Circles: median read depth (left Y
axis). Triangles: % genome coverage (right Y axis).
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these discrepancies is unclear.
3.4. Potential utilisation of WGS for non-culture cases in England and
Wales
The genome quality results produced from the specimen panel
during this study were used to estimate the proportion of non-culture
cases conﬁrmed by the MRU that could be successfully sequenced using
this technique. The results of this study suggest that ≥100 pg is re-
quired to produce a genome of suﬃcient quality to provide typing data
and extended MLST analyses. To put this in context, the meningococcal
DNA loads of hypothetical clinical specimens were estimated based on
Ct values and specimen volumes (Supplementary Table 2). The esti-
mated DNA loads indicate that samples with Ct values of> 30 contain
less than 100 pg (at any volume) and would, therefore, be unlikely to
produce acceptable genomic data. From January to December 2016,
54.5% of the non-culture specimens conﬁrmed by the MRU produced a
Ct value of> 30. Conversely, samples with Ct ≤26 (23.4% of 2016
specimens) are predicted to produce acceptable genomes even if only
25 μL of volume is available for extraction. For specimens with Ct va-
lues between 26 and 31, the volume of specimen available is likely to be
the key determinant of successful WGS (Supplementary Table 2).
4. Discussion
The inability to perform standard WGS from non-culture specimens
limits the extent of strain characterisation for around half of IMD cases
in England and Wales. Genome sequencing from these samples would
support the enhanced surveillance of vaccine antigens and investiga-
tions into potential vaccine failures. Recent studies have indicated that
genomic data can be used to characterise antigenic promoter regions
and, to some degree, predict the expression level of important vaccine
antigens (Biagini et al., 2016). Genomic data have also been important
in identifying newly-emerging invasive sub-lineages and diﬀerentiating
potential outbreak strains (Chatt et al., 2014; Lucidarme et al., 2015;
Tzeng et al., 2017). The MRU has been collecting and storing clinical
specimens from conﬁrmed IMD cases since 1996, and in recent years,
the vast majority of residual non-culture material has been retained.
The DNA within these specimens represents a genetic ‘snap shot’ mid-
infection. The ability to perform WGS on these materials may provide
opportunities to improve our understanding of meningococcal viru-
lence as well as allowing us to paint a more accurate picture of the
rapidly-changing epidemiological landscape.
In this study we have demonstrated the ability to enrich and se-
quence diverse group B meningococcal genomes directly from blood
and CSF specimens using RNA baits to capture the meningococcal DNA
fragments. Eight of the ten specimens tested produced draft genomes of
acceptable genomic coverage and read depth. A lack of genomic data
from the remaining two specimens was likely to be due to the low
amount of meningococcal DNA within the specimens.
To assess the accuracy of this enrichment and sequencing technique,
basic comparisons between the specimen genomes and the genomes of
corresponding isolates (i.e. from the same patient) were performed. The
genomes sequenced from puriﬁed isolate DNA contained fewer contigs
than those from clinical specimens, and in most cases featured more
annotated genes. Despite screening for human reads prior to assembly,
the longer cumulative contig length among the specimen genomes
suggests human sequences (or other contaminating DNA) were included
in the genomic data. All of the commonly-used typing information
(MLST, vaccine antigens, etc.) matched between the paired genomes,
however, there were some allelic discrepancies amongst the indexed
NEIS loci (as deﬁned by PubMLST). Almost all of these are likely to be
the result of PCR error and/or artefacts of read mis-assembly within
paralogous genes. One non-paralogous locus, rpsP (NEIS0534), en-
coding a highly-conserved ribosomal protein, featured four nucleotide
diﬀerences between the paired genomes. An explanation for these dis-
crepancies is not apparent, however, it could possibly be indicative of
contaminating DNA within the assembly. Other than these diﬀerences,
all genome pairs were highly congruent demonstrating the accuracy of
the direct WGS protocol. One limitation of these comparisons was the
lack of standardisation of assembly/sequencing methods between the
culture and specimen genomes. The inﬂuence of DNA target enrichment
on sequence quality is, therefore, hard to assess accurately. Future
studies controlling for such variables would provide a more detailed
comparison of genome quality from the diﬀerent DNA sources.
In the SureSelectXT system, RNA bait sequences are generated using
genomic data from the target organism. N. meningitidis exhibits high
homologous recombination rates, which may hinder the cross-reactivity
of the RNA capture baits (Vos and Didelot, 2009). In this study, data
from 2975 meningococcal genomes were used to generate the bait se-
quences. This panel was highly biased towards the major hyper-virulent
lineages with>75% of the strains belonging to one of only seven
clonal complexes (data not shown). Whilst this does raise questions
about the ability of the baits to enrich DNA belonging to less common
invasive lineages and/or carriage strains, the Perl script used to gen-
erate the baits is designed to remove redundancy and prevent bias
Table 3
Contig properties, extracted typing data and locus overview of ten non-culture genomes and corresponding isolate genomes.
Filled dark gray boxes represent missing typing data.
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towards predominant sequences. In this case, the baits appeared to be
eﬀective against diverse group B strains, however, the variation in DNA
amount across the specimen panel made it diﬃcult to identify any
diﬀerences in the eﬃciency of the hybridisation between the diﬀerent
lineages. This represents another aspect of N. meningitidis DNA enrich-
ment that requires further evaluation.
From these preliminary results we conclude that at least∼100 pg of
meningococcal DNA is required to generate genomes of suﬃcient
quality, whilst using>500 pg in the library preparation results in a
greater proportion of on-target reads and yields genomes with fewer
interrupted/incomplete genes. Consequently, along with the Ct value,
the volume of extract/specimen available could be a major factor in the
likelihood of obtaining a genome of suﬃcient quality. The estimated
meningococcal DNA concentrations within the clinical specimens were
calculated using a standard curve of Ct values and quantiﬁed DNA
concentrations of meningococcal isolate extracts (Clark et al., 2014).
Whether Ct values from puriﬁed isolate extracts correlate with the Ct
values from clinical specimens, which contain non-meningococcal DNA
and possible PCR inhibitors, is unclear. Nonetheless, we believe these
values are likely to provide a reasonable approximation.
A key disadvantage of the SureSelectXT Target Enrichment system is
the signiﬁcantly greater ﬁnancial cost in relation to WGS from isolates.
Whilst this system is likely to be more eﬃcient than multiple nested
PCR sequencing assays in terms of the number of loci characterised and
the laboratory time required, the current reagent costs may be too high
to justify routine WGS of all non-culture cases. Analysis of speciﬁc
samples of interest (e.g. those from outbreaks or potential vaccine
failures) would, however, be feasible and could provide pivotal in-
formation to guide public health responses.
It was estimated that up to 45% of recent non-culture specimens
could be successfully genome sequenced using this technique, and
∼25% of specimens should yield genomes with complete typing data.
Further measures to optimise DNA extraction, deplete non-target DNA
prior to enrichment and/or redesign the RNA bait library have pre-
viously been shown to improve the quality of the pathogen genome
obtained (Brown et al., 2015). Future optimisation of the extraction/
enrichment process may increase the proportion of non-culture IMD
cases from which genomes can be sequenced.
5. Conclusions
The generation of draft meningococcal genomes directly from
clinical specimens was achieved using the Agilent SureSelectXT kit.
Estimations suggest that almost half of the non-culture IMD specimens
received by the MRU may yield acceptable genomic data, however,
further method optimisation may help to increase this proportion. The
current high ﬁnancial cost associated with the enrichment process may
preclude routine WGS of all non-culture invasive strains.
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